ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 76 filers reported holding ARCUS BIOSCIENCES INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $651,585 | -14.7% | 36,300 | -3.5% | 0.00% | 0.0% |
Q2 2023 | $763,656 | -63.7% | 37,600 | -67.4% | 0.00% | -60.0% |
Q1 2023 | $2,104,896 | -40.9% | 115,400 | -33.0% | 0.01% | -50.0% |
Q4 2022 | $3,563,164 | -22.1% | 172,300 | -1.4% | 0.01% | -23.1% |
Q3 2022 | $4,573,000 | +34.8% | 174,800 | +30.5% | 0.01% | +30.0% |
Q2 2022 | $3,393,000 | -30.5% | 133,900 | -13.5% | 0.01% | -23.1% |
Q1 2022 | $4,885,000 | -56.3% | 154,800 | -43.9% | 0.01% | -53.6% |
Q4 2021 | $11,170,000 | +10.0% | 276,000 | -5.3% | 0.03% | +7.7% |
Q3 2021 | $10,158,000 | -1.8% | 291,300 | -22.6% | 0.03% | -3.7% |
Q2 2021 | $10,339,000 | -21.1% | 376,500 | -19.3% | 0.03% | -25.0% |
Q1 2021 | $13,097,000 | +2.7% | 466,400 | -5.0% | 0.04% | +5.9% |
Q4 2020 | $12,749,000 | +36.1% | 491,100 | -10.2% | 0.03% | +25.9% |
Q3 2020 | $9,369,000 | +50.2% | 546,600 | +116.8% | 0.03% | +50.0% |
Q2 2020 | $6,237,000 | +505.5% | 252,100 | +239.8% | 0.02% | +350.0% |
Q1 2020 | $1,030,000 | +39.2% | 74,200 | +1.2% | 0.00% | +100.0% |
Q4 2019 | $740,000 | – | 73,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 1,612,077 | $65,241,000 | 19.83% |
Octagon Capital Advisors LP | 2,095,231 | $84,794,000 | 16.50% |
EcoR1 Capital, LLC | 5,523,358 | $223,530,000 | 7.12% |
BVF INC/IL | 3,398,067 | $137,520,000 | 4.99% |
PFM Health Sciences, LP | 3,431,010 | $138,853,000 | 4.73% |
Alphabet Inc. | 2,563,441 | $103,742,000 | 2.50% |
Boxer Capital, LLC | 1,432,200 | $57,961,000 | 2.25% |
PARK CIRCLE Co | 64,000 | $2,590,000 | 2.04% |
SECTORAL ASSET MANAGEMENT INC | 283,210 | $11,462,000 | 1.72% |
DAFNA Capital Management LLC | 117,200 | $4,743,000 | 1.19% |